QID 240363

Date Published: 2022-05-30

QID 240363: Red Hat Update for rhv engine and host common packages (RHSA-2022:4712)

the ovirt-engine package provides the Red Hat virtualization manager, a centralized management platform that allows system administrators to view and manage virtual machines.
The manager provides a comprehensive range of features including search capabilities, resource management, live migrations, and virtual infrastructure provisioning.

Security Fix(es):

python-paramiko: race condition in the write_private_key_file function (cve-2022-24302)

Affected Products:

Red Hat virtualization manager 4.4 x86_64
Red Hat virtualization 4 for rhel 8 x86_64
Red Hat virtualization for ibm power le 4 for rhel 8 ppc64le
Red Hat enterprise linux for x86_64 8 x86_64
Red Hat enterprise linux for power, little endian 8 ppc64le

Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a security breach or could affect integrity, availability, and confidentiality.

CVSS V3 rated as Medium - 5.9 severity.

CVSS V2 rated as Medium - 4.3 severity.

Solution

Refer to Red Hat security advisory RHSA-2022:4712 for updates and patch information.

Vendor References

RHSA-2022:4712 - access.redhat.com/errata/RHSA-2022:4712

CVEs related to QID 240363

CVE-2022-24302 |

Software Advisories

Advisory ID	Software	Component	Link
RHSA-2022:4712	Red Hat Enterprise Linux		access.redhat.com/errata/RHSA-2022:4712

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].